HealthPhoto: FirstpostPopVax CEO Discusses Experimental Personalized Cancer Vaccines
PopVax, a Hyderabad-based startup, is developing custom tumour-targeting vaccines through its new RNA Foundry. CEO Soham Sankaran emphasizes that these personalized cancer vaccines are still experimental and not an established cure. He explains the vaccine design process and shares insights on the future of oncology care, highlighting ongoing innovation in cancer treatment technology.
Firstpost··Hyderabad


